<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07004</article-id><article-id pub-id-type="doi">10.7554/eLife.07004</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title><italic>MicroRNA-203</italic> represses selection and expansion of oncogenic <italic>Hras</italic> transformed tumor initiating cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-29341"><name><surname>Riemondy</surname><given-names>Kent</given-names></name><aff><institution content-type="dept">Department of Molecular, Cellular and Developmental Biology</institution>, <institution>University of Colorado, Boulder</institution>, <addr-line><named-content content-type="city">Boulder</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29342"><name><surname>Wang</surname><given-names>Xiao-jing</given-names></name><aff><institution content-type="dept">Department of Pathology</institution>, <institution>University of Colorado Denver Anschutz Medical Campus</institution>, <addr-line><named-content content-type="city">Denver</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29343"><name><surname>Torchia</surname><given-names>Enrique C</given-names></name><aff><institution content-type="dept">Department of Dermatology</institution>, <institution>University of Colorado Denver Anschutz Medical Campus</institution>, <addr-line><named-content content-type="city">Denver</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27225"><name><surname>Roop</surname><given-names>Dennis R</given-names></name><aff><institution content-type="dept">Department of Dermatology</institution>, <institution>University of Colorado Denver Anschutz Medical Campus</institution>, <addr-line><named-content content-type="city">Denver</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-9464"><name><surname>Yi</surname><given-names>Rui</given-names></name><aff><institution content-type="dept">Department of Molecular, Cellular and Developmental Biology</institution>, <institution>University of Colorado, Boulder</institution>, <addr-line><named-content content-type="city">Boulder</named-content></addr-line>, <country>United States</country><email>yir@colorado.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1069"><name><surname>Dang</surname><given-names>Chi Van</given-names></name><role>Reviewing editor</role><aff><institution>University of Pennsylvania</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>07</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e07004</elocation-id><supplementary-material><ext-link xlink:href="elife-07004-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>13</day><month>02</month><year>2015</year></date><date date-type="accepted"><day>22</day><month>07</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Riemondy et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Riemondy et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>In many mouse models of skin cancer, only a few tumors typically form even though many cells competent for tumorigenesis receive the same oncogenic stimuli. These observations suggest an active selection process for tumor-initiating cells. Here we use quantitative mRNA- and miR-Seq to determine the impact of <italic>Hras<sup>G12V</sup></italic> on the transcriptome of keratinocytes. We discover that <italic>microRNA-203</italic> is downregulated by <italic>Hras<sup>G12V</sup></italic>. Using a knockout mouse model, we demonstrate that loss of <italic>microRNA-203</italic> promotes selection and expansion of tumor-initiating cells. Conversely, restoration of <italic>microRNA-203</italic> using an inducible model potently inhibits proliferation of these cells. We comprehensively identify <italic>microRNA-203</italic> targets required for <italic>Hras</italic>-initiated tumorigenesis. These targets include critical regulators of the <italic>Ras</italic> pathway and essential genes required for cell division. This study establishes a role for the loss of <italic>microRNA-203</italic> in promoting selection and expansion of <italic>Hras</italic> mutated cells and identifies a mechanism through which <italic>microRNA-203</italic> antagonizes <italic>Hras</italic>-mediated tumorigenesis.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#1408.01) of the University of Colorado, Boulder. Every effort was made to minimize suffering.</p></fn></fn-group></back></article>